Résumé
Skills: Regulatory Affairs, Clinical Research, Risk and Projects Management (PMI), Audit in Healthcare companies (drugs, medical devices, cells therapy products), Quality & Environment Management.
Expériences professionnelles
Head of clinical dpt
Eurofins E&E France
Depuis le 02 avril 2024

Co-chair leadership team lng france
Regulatory Affairs Professionals Society (RAPS)
Depuis le 02 janvier 2023

Gmed trainer, clinical evaluation & investigation training
GMED
De Septembre 2021 à Août 2024

Board member association la roche (mission: psychic disability support)
Association La Roche
Depuis le 02 juillet 2021

Director clinical & regulatory - chairman & founder
CR MED CONSULTING
De Février 2021 à Août 2024
Having earned a Doctorate in Pharmacy and an MSc in Quality, I have a passion for public healthcare.
Prior experience was working for Japanese, US-based, and French companies dealing with medical devices, drugs, and cells therapy products for over 30 years. As RA International Director in previous experiences, I have developed, implemented, and maintained regulatory strategies and guidance based on international requirements for all classes of medical devices.
I also have experience in Quality in establishing, maintaining ISO13485 (audits, inspections) and in Clinical Research where I was responsible for managing more than 20 international clinical trials.
I have been actively involved in company executive strategy as a Business Board member (over 15 yrs) and member of French (snitem) and European (MedTech Europe) industrial associations,
More recently I was responsible for leading MDR compliance as a Person Responsible for Regulatory Compliance (PRRC) and international registrations.
Today, at CR MED Consulting I am committed to sharing my compliance experience as a Consultant to support healthcare companies, train in Clinical and Regulatory activities (GMED contract teacher) and to participating actively in AFAR, RAPS, and Team-PRRC Associations.
Director of regulatory affairs
THUASNE
De Janvier 2019 à Décembre 2020

- Member of the Business Board
- Develop, maintain regulatory strategies and product compliance, Technical Documentation (STED) of medical devices according to Medical Device Regulation (MDR), other international registrations (export), current standards, Eudamed process.
- Develop, maintain strategies of the Post Market (PMS Plan & Report, Promotional material, Vigilance (MIR, IMDRF codification), and Clinical Evaluation processes (CEP, CDP & CER); support to Biological Safety Report, usability, risk management, etc.
Dir. regulatory affairs, clinical & qa
3-D Matrix Europe
De Décembre 2015 à Décembre 2018

Registrations, EC Marking, regulatory strategies for the current and new medical devices (class III implantable, etc.) in relation with Competent authorities and Notify Body. MDD and MDR (2017/745)
QMS (ISO13485:2016, MDSAP) and Vigilance management
Clinical Affairs management and support to Reimbursement (MEDDEV 2.7.1 rev 4)
ansm inspection
International regulatory affairs director
Integra LifeSciences
De Juin 2014 à Novembre 2015

.Registrations, reimbursement and regulatory strategies in Asia Pacific, Canada, Latin America and EMEA based on International requirements.
.Effective dialogue with Competent regulatory Authorities, Vigilance of Integra product lines (Human Tissue Products (HTP) and Medical Device (MD)).
. Member of the Business Board
Emea director, regulatory & clinical affairs, reimbursement - quality
Integra LifeSciences
De Mars 2011 à Novembre 2015

Ensure support of the company's business objectives, develop and implement regulatory & reimbursement strategies and guidance in EMEA (Europe, Middle East, Africa). Coordinate all pre- and post- market clinical studies organized on EMEA market for company's products, the EMEA Speakers Bureau
Process coordination, quality & environment director
LABORATOIRES GENEVRIER
De Juin 2009 à Mars 2011

- Member of the Business Board
- Clinical Research Director
- Development process and portfolio management
Set up an Integrated Portfolio Mgmt Process
- Quality & Environment
R&d quality evaluation, global manager
BIOMERIEUX
De Février 2007 à Novembre 2008

management of the R&D process indicators and metrics (worldwide) in order to measure the performance
internal audit and supplier audit
...